NME3

There is 1 paper on NME3 in aging research: 1 observational study in people.

Gene

1 paper studies it1 finding

HGNCNCBI GeneTaxon

1 new paper in 30 daysSee all 1 papers on NME3

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“genetic evidence implicates PARP1, SPINT2 and NME3 in increased risk.”
Prospective and genetic analyses implicate lower immunosurveillance in the aetiology of prostate cancerNature communications2026doi:10.1038/s41467-026-77378-3
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funder: Cancer Research UK
  • Humans1

Associations

1

Prostate cancer

upin humans1

1 study
  1. NME3 is linked with a higher risk of prostate cancer in humans (genetic evidence).

    “genetic evidence implicates PARP1, SPINT2 and NME3 in increased risk.”

    Humansgenetic evidencemales

    Prospective and genetic analyses implicate lower immunosurveillance in the aetiology of prostate cancer

    Nature communications

More on Prostate cancer

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months